These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 35881936

  • 1. Correlation between plasma sphingosine-1-phosphate and the occurrence and severity of coronary heart disease in postmenopausal women.
    Deng S, Ao Z, Liu B, She Q, Du J, Liu Y, Jing X.
    Menopause; 2022 Aug 01; 29(8):920-925. PubMed ID: 35881936
    [Abstract] [Full Text] [Related]

  • 2. The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Bae SJ, Lee SH, Ahn SH, Kim HM, Kim BJ, Koh JM.
    Osteoporos Int; 2016 Aug 01; 27(8):2533-41. PubMed ID: 26984570
    [Abstract] [Full Text] [Related]

  • 3. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
    Yafasova A, Mandrup CM, Egelund J, Nyberg M, Stallknecht B, Hellsten Y, Nielsen LB, Christoffersen C.
    J Appl Physiol (1985); 2019 Jan 01; 126(1):214-220. PubMed ID: 30433864
    [Abstract] [Full Text] [Related]

  • 4. Associations of Circulating Levels of Sphingosine 1-Phosphate with the Trabecular Bone Score and Bone Mineral Density in Postmenopausal Women.
    Lee SH, Lee JY, Lim KH, Lee YS, Kim SH, Choi S, Cho SH, Kim JS, Koh JM.
    J Clin Densitom; 2021 Jan 01; 24(3):414-421. PubMed ID: 33846060
    [Abstract] [Full Text] [Related]

  • 5. Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women.
    Kim BJ, Koh JM, Lee SY, Lee YS, Lee SH, Lim KH, Cho EH, Kim SW, Kim TH, Kim SY, Kim GS.
    J Clin Endocrinol Metab; 2012 Oct 01; 97(10):3807-14. PubMed ID: 22879631
    [Abstract] [Full Text] [Related]

  • 6. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans.
    Lee SH, Lee SY, Lee YS, Kim BJ, Lim KH, Cho EH, Kim SW, Koh JM, Kim GS.
    J Clin Endocrinol Metab; 2012 Aug 01; 97(8):E1421-8. PubMed ID: 22679064
    [Abstract] [Full Text] [Related]

  • 7. Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen.
    Guo S, Yu Y, Zhang N, Cui Y, Zhai L, Li H, Zhang Y, Li F, Kan Y, Qin S.
    Biochim Biophys Acta; 2014 Jun 01; 1841(6):836-46. PubMed ID: 24603322
    [Abstract] [Full Text] [Related]

  • 8. High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study.
    Ardawi MM, Rouzi AA, Al-Senani NS, Qari MH, Elsamanoudy AZ, Mousa SA.
    J Bone Metab; 2018 May 01; 25(2):87-98. PubMed ID: 29900158
    [Abstract] [Full Text] [Related]

  • 9. Familial hypercholesterolaemia: cholesterol efflux and coronary disease.
    Versmissen J, Vongpromek R, Yahya R, van der Net JB, van Vark-van der Zee L, Blommesteijn-Touw J, Wattimena D, Rietveld T, Pullinger CR, Christoffersen C, Dahlbäck B, Kane JP, Mulder M, Sijbrands EJ.
    Eur J Clin Invest; 2016 Jul 01; 46(7):643-50. PubMed ID: 27208892
    [Abstract] [Full Text] [Related]

  • 10. Association of circulating levels of total and protein-bound sphingosine 1-phosphate with osteoporotic fracture.
    Song HE, Lee SH, Kim SJ, Kim BJ, Yoo HJ, Koh JM.
    J Investig Med; 2020 Oct 01; 68(7):1295-1299. PubMed ID: 32675084
    [Abstract] [Full Text] [Related]

  • 11. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis.
    Sattler K, Lehmann I, Gräler M, Bröcker-Preuss M, Erbel R, Heusch G, Levkau B.
    Cell Physiol Biochem; 2014 Oct 01; 34(1):172-84. PubMed ID: 24977490
    [Abstract] [Full Text] [Related]

  • 12. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    Becker S, Kinny-Köster B, Bartels M, Scholz M, Seehofer D, Berg T, Engelmann C, Thiery J, Ceglarek U, Kaiser T.
    PLoS One; 2017 Oct 01; 12(3):e0174424. PubMed ID: 28334008
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
    Jing XD, Wei XM, Deng SB, Du JL, Liu YJ, She Q.
    Clin Chim Acta; 2015 Jun 15; 446():248-52. PubMed ID: 25958848
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.
    Yan XN, Jin JL, Hong LF, Guo YL, Wu NQ, Zhu CG, Dong Q, Li JJ.
    J Womens Health (Larchmt); 2020 Apr 15; 29(4):503-510. PubMed ID: 31905317
    [Abstract] [Full Text] [Related]

  • 15. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Gräler MH, Bröcker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B.
    Basic Res Cardiol; 2010 Nov 15; 105(6):821-32. PubMed ID: 20652276
    [Abstract] [Full Text] [Related]

  • 16. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
    Polzin A, Piayda K, Keul P, Dannenberg L, Mohring A, Gräler M, Zeus T, Kelm M, Levkau B.
    J Mol Cell Cardiol; 2017 Sep 15; 110():35-37. PubMed ID: 28709768
    [Abstract] [Full Text] [Related]

  • 17. High Circulating Sphingosine 1-Phosphate is a Risk Factor for Osteoporotic Fracture Independent of Fracture Risk Assessment Tool.
    Lee SH, Lee JY, Lim KH, Lee YS, Kim SH, Choi S, Cho SH, Koh JM.
    Calcif Tissue Int; 2020 Oct 15; 107(4):362-370. PubMed ID: 32719936
    [Abstract] [Full Text] [Related]

  • 18. U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: a prospective cohort study.
    Xue Y, Jiang W, Ma Q, Wang X, Jia P, Li Q, Chen S, Song B, Wang Y, Zhang J, Liu J, Yang G, Lin Y, Liu J, Wei L, Dong C, Li H, Xie Z, Bai L, Ma A.
    Lipids Health Dis; 2020 Jun 04; 19(1):125. PubMed ID: 32498720
    [Abstract] [Full Text] [Related]

  • 19. Urinary Sphingosine-1-Phosphate as a Biomarker for Bladder Pain Syndrome.
    Eggers E, Crouss T, Lipetskaia L, DiSanto M.
    Urogynecology (Phila); 2024 Mar 01; 30(3):374-380. PubMed ID: 38484256
    [Abstract] [Full Text] [Related]

  • 20. Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.
    Wu X, Hou J, Li H, Xie G, Zhang X, Zheng J, Wang J, Gao F, Yao Y, Liu H, Fang X.
    Shock; 2019 Jun 01; 51(6):718-724. PubMed ID: 30080743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.